Dark Horse Consulting Group, a leading strategic and operational consulting enterprise in the field of biological therapy (hereinafter referred to as " DHC...
•MacroGenics to receive $122.5 million upfront payment from Bora upon closing•Transaction includes transfer of manufacturing site, CDMO operati...
Creates Standalone Leader in Advanced Therapy Manufacturing with Decades of Proven Experience and Continued Commitment to Client Service Dedicated Resou...
Eli Lilly and Company has announced an additional US$4.5 billion investment into its Indiana manufacturing network, deepening one of the mo...
Investment Strengthens American Manufacturing, Supply Chain Resilience and Next-Generation Technology Amgen announced plans to invest an additional $300...
New Gibco™ CTS™ DynaXS™ Single Use Bioreactor supports flexible, cGMP-ready cell expansion from process development to clinical p...
Cytiva, a Danaher company and a leader in the life sciences industry, and Rockwell Automation, Inc. (NYSE: ROK), the world’s larg...
LTS LOHMANN Therapie-Systeme AG ("LTS"), a leading pharmaceutical technology company specializing in advanced drug delivery systems, announced the expans...
Kytopen partners with T-CURX and the Fraunhofer Institute for Cell Therapy and Immunology (IZI) in Würzburg and Leipzig, Germany to establish a jo...
Expansion of Plainville, Mass., facility offers bioprocessing expertise, advanced technologies and customized support Thermo Fisher Scientific Inc...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it has signed a definitive agreement to sell its microbiol...
PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on i...
U.S. Food and Drug Administration (FDA) issues Complete Response Letter (CRL) for trenibotulinumtoxinE (TrenibotE) related to manufacturing processes; ...
Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended Ma...
© 2026 Biopharma Boardroom. All Rights Reserved.
